ChoA Pharmaceutical Co., LTD.
Research ChoA Pharmaceutical Co., LTD. (034940.KQ) on Bullrun: market cap KRW 13.20B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker034940.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 13.20B
- Financial periodQ2 2026
- RevenueKRW 15.18B
- Net incomeKRW 499.77M
- Free cash flow-KRW 546.38M
- Gross margin38.2%
Valuation Snapshot
latest market cap is KRW 13.20B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 13.20B | n/a | n/a | n/a |
Dividend history
About ChoA Pharmaceutical Co., LTD.
ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral nervous system; gynecologic diseases; antibiotics, antigens, and anthelmintic;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ChoA Pharmaceutical Co., LTD.'s market cap?
ChoA Pharmaceutical Co., LTD.'s market capitalization is KRW 13.20B.
What does ChoA Pharmaceutical Co., LTD. do?
ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral nervous system; gynecologic diseases; antibiotics, antigens, and anthelmintic; and antitumor, as well as other metabolite medicines.